| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | steroid hormone binding | 9.41e-07 | 7 | 61 | 3 | GO:1990239 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.00e-06 | 109 | 61 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 3.21e-06 | 10 | 61 | 3 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 3.21e-06 | 10 | 61 | 3 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 4.31e-06 | 36 | 61 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 4.31e-06 | 36 | 61 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 4.40e-06 | 11 | 61 | 3 | GO:0008556 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 8.90e-06 | 43 | 61 | 4 | GO:0043548 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.71e-05 | 178 | 61 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 3.85e-05 | 62 | 61 | 4 | GO:0019829 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 5.49e-05 | 4 | 61 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.61e-05 | 441 | 61 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 8.13e-05 | 465 | 61 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 NLRP10 IGHMBP2 ATP6V0A4 ATP1A1 ATP1A2 ATP1A3 POLQ ABCB1 | 9.65e-05 | 614 | 61 | 9 | GO:0140657 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A1 CACNG6 TRPM5 PKD1L1 ATP6V0A4 ATP1A1 MAGT1 ATP1A2 ATP1A3 | 1.13e-04 | 627 | 61 | 9 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A1 CACNG6 TRPM5 PKD1L1 ATP6V0A4 ATP1A1 MAGT1 ATP1A2 ATP1A3 | 1.74e-04 | 664 | 61 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.75e-04 | 171 | 61 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 2.54e-04 | 8 | 61 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 4.25e-04 | 48 | 61 | 3 | GO:0032266 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A1 CACNG6 TRPM5 PKD1L1 ATP6V0A4 ATP1A1 MAGT1 ATP1A2 ATP1A3 | 4.61e-04 | 758 | 61 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 6.08e-04 | 477 | 61 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A1 CACNG6 TRPM5 PKD1L1 ATP6V0A4 ATP1A1 MAGT1 ATP1A2 ATP1A3 | 6.39e-04 | 793 | 61 | 9 | GO:0015075 |
| GeneOntologyMolecularFunction | steroid binding | 7.32e-04 | 133 | 61 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A1 ABCA1 CACNG6 TRPM5 PKD1L1 ATP6V0A4 ATP1A1 MAGT1 ATP1A2 ATP1A3 ABCB1 | 8.00e-04 | 1180 | 61 | 11 | GO:0022857 |
| GeneOntologyMolecularFunction | potassium ion binding | 8.16e-04 | 14 | 61 | 2 | GO:0030955 | |
| GeneOntologyMolecularFunction | D1 dopamine receptor binding | 8.16e-04 | 14 | 61 | 2 | GO:0031748 | |
| GeneOntologyMolecularFunction | sodium ion binding | 8.16e-04 | 14 | 61 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 9.40e-04 | 15 | 61 | 2 | GO:0043560 | |
| GeneOntologyMolecularFunction | floppase activity | 1.07e-03 | 16 | 61 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 1.52e-03 | 19 | 61 | 2 | GO:0031434 | |
| GeneOntologyMolecularFunction | transporter activity | SLC6A1 ABCA1 CACNG6 TRPM5 PKD1L1 ATP6V0A4 ATP1A1 MAGT1 ATP1A2 ATP1A3 ABCB1 | 1.64e-03 | 1289 | 61 | 11 | GO:0005215 |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.68e-03 | 20 | 61 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 1.68e-03 | 20 | 61 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.70e-03 | 167 | 61 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | peptide hormone receptor binding | 1.86e-03 | 21 | 61 | 2 | GO:0051428 | |
| GeneOntologyMolecularFunction | ankyrin binding | 2.23e-03 | 23 | 61 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.25e-03 | 301 | 61 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.37e-03 | 775 | 61 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | dopamine receptor binding | 2.85e-03 | 26 | 61 | 2 | GO:0050780 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.85e-03 | 26 | 61 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.30e-03 | 28 | 61 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | insulin receptor binding | 3.78e-03 | 30 | 61 | 2 | GO:0005158 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 3.85e-03 | 839 | 61 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hormone binding | 3.86e-03 | 103 | 61 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 3.88e-03 | 840 | 61 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.88e-03 | 840 | 61 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | hormone receptor binding | 4.84e-03 | 34 | 61 | 2 | GO:0051427 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 5.41e-03 | 36 | 61 | 2 | GO:0070273 | |
| GeneOntologyMolecularFunction | calcium channel activity | 7.22e-03 | 129 | 61 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 7.22e-03 | 129 | 61 | 3 | GO:0035591 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 7.31e-03 | 42 | 61 | 2 | GO:0071889 | |
| GeneOntologyBiologicalProcess | response to glycoside | 2.45e-07 | 5 | 61 | 3 | GO:1903416 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of transmembrane electrochemical gradient | 3.99e-06 | 11 | 61 | 3 | GO:0010248 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 7.32e-06 | 91 | 61 | 5 | GO:0140115 | |
| GeneOntologyBiologicalProcess | intracellular potassium ion homeostasis | 1.62e-05 | 17 | 61 | 3 | GO:0030007 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 1.62e-05 | 17 | 61 | 3 | GO:0036376 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 6.10e-05 | 26 | 61 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | sphingolipid translocation | 8.55e-05 | 5 | 61 | 2 | GO:0099039 | |
| GeneOntologyBiologicalProcess | intracellular sodium ion homeostasis | 9.44e-05 | 30 | 61 | 3 | GO:0006883 | |
| GeneOntologyBiologicalProcess | export from cell | JAK2 ABCA1 PTPN11 MAOB PLA2G4A IRS1 ATP1A1 ATP1A2 ATP1A3 GRM8 ALOX5 ABCB1 | 1.20e-04 | 1153 | 61 | 12 | GO:0140352 |
| GeneOntologyBiologicalProcess | corpus callosum development | 1.26e-04 | 33 | 61 | 3 | GO:0022038 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 1.51e-04 | 35 | 61 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | central nervous system development | DAB2IP SOX12 DMXL2 BRINP3 PTPN11 MAOB SZT2 CORO1C IGHMBP2 ATP1A2 ATP1A3 ABCB1 | 1.71e-04 | 1197 | 61 | 12 | GO:0007417 |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 1.78e-04 | 37 | 61 | 3 | GO:0055075 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 2.20e-04 | 100 | 61 | 4 | GO:0061337 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | DMXL2 ABCA1 PTPN11 FRRS1 ATP6V0A4 PLA2G4A IRS1 ATP1A1 ATP1A2 ATP1A3 ACE ALOX5 | 2.53e-04 | 1249 | 61 | 12 | GO:0048878 |
| GeneOntologyBiologicalProcess | cellular response to lipid | 3.31e-04 | 748 | 61 | 9 | GO:0071396 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.74e-04 | 208 | 61 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | amino acid neurotransmitter reuptake | 3.81e-04 | 10 | 61 | 2 | GO:0051933 | |
| GeneOntologyBiologicalProcess | response to lipid | DAB2IP SLC6A1 JAK2 BRINP3 ABCA1 MAOB IRS1 ATP1A1 ATP1A2 ATP1A3 ACE | 4.13e-04 | 1126 | 61 | 11 | GO:0033993 |
| GeneOntologyBiologicalProcess | telencephalon development | 4.38e-04 | 332 | 61 | 6 | GO:0021537 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 4.63e-04 | 51 | 61 | 3 | GO:1990573 | |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 4.63e-04 | 51 | 61 | 3 | GO:0055078 | |
| GeneOntologyCellularComponent | plasma membrane raft | 3.27e-06 | 147 | 58 | 6 | GO:0044853 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 4.38e-06 | 12 | 58 | 3 | GO:0005890 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DAB2IP SLC6A1 TANC2 BRINP3 TRPM5 MAOB IGHMBP2 CPEB3 ATP1A2 ATP1A3 PARD3 GRM8 ALOX5 PDE11A | 4.80e-06 | 1228 | 58 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 1.03e-05 | 49 | 58 | 4 | GO:0090533 | |
| GeneOntologyCellularComponent | caveola | 1.41e-05 | 111 | 58 | 5 | GO:0005901 | |
| GeneOntologyCellularComponent | sarcolemma | 1.42e-05 | 190 | 58 | 6 | GO:0042383 | |
| GeneOntologyCellularComponent | neuronal cell body | DAB2IP SLC6A1 BRINP3 TRPM5 MAOB IGHMBP2 ATP1A2 ATP1A3 PARD3 GRM8 PDE11A | 1.58e-05 | 835 | 58 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 1.64e-05 | 55 | 58 | 4 | GO:0098533 | |
| GeneOntologyCellularComponent | cell body | DAB2IP SLC6A1 BRINP3 TRPM5 MAOB IGHMBP2 ATP1A2 ATP1A3 PARD3 GRM8 PDE11A | 4.21e-05 | 929 | 58 | 11 | GO:0044297 |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 4.52e-05 | 4 | 58 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | membrane raft | 6.20e-05 | 362 | 58 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 6.42e-05 | 364 | 58 | 7 | GO:0098857 | |
| GeneOntologyCellularComponent | GATOR2 complex | 4.91e-04 | 12 | 58 | 2 | GO:0061700 | |
| GeneOntologyCellularComponent | dendrite | 5.54e-04 | 858 | 58 | 9 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 5.64e-04 | 860 | 58 | 9 | GO:0097447 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 5.88e-04 | 523 | 58 | 7 | GO:1902495 | |
| GeneOntologyCellularComponent | membrane protein complex | JAK2 CACNG6 TRPM5 CORO1C PKD1L1 ATP6V0A4 IRS1 ATP1A1 MAGT1 ATP1A2 ATP1A3 SEC31B | 7.13e-04 | 1498 | 58 | 12 | GO:0098796 |
| GeneOntologyCellularComponent | transporter complex | 7.91e-04 | 550 | 58 | 7 | GO:1990351 | |
| GeneOntologyCellularComponent | Seh1-associated complex | 8.86e-04 | 16 | 58 | 2 | GO:0035859 | |
| GeneOntologyCellularComponent | T-tubule | 1.38e-03 | 79 | 58 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | myelin sheath | 3.09e-03 | 217 | 58 | 4 | GO:0043209 | |
| HumanPheno | Episodic quadriplegia | 2.31e-05 | 2 | 25 | 2 | HP:0200072 | |
| Domain | P-type_ATPase_IIC | 6.26e-07 | 6 | 60 | 3 | IPR005775 | |
| Domain | - | 1.71e-05 | 16 | 60 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 1.71e-05 | 16 | 60 | 3 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.08e-05 | 17 | 60 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.08e-05 | 17 | 60 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 2.49e-05 | 18 | 60 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 2.49e-05 | 18 | 60 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.94e-05 | 19 | 60 | 3 | IPR004014 | |
| Domain | NUT | 1.01e-04 | 5 | 60 | 2 | IPR024310 | |
| Domain | NUT_N | 1.01e-04 | 5 | 60 | 2 | IPR024309 | |
| Domain | NUT | 1.01e-04 | 5 | 60 | 2 | PF12881 | |
| Domain | - | 1.46e-04 | 32 | 60 | 3 | 3.40.1110.10 | |
| Domain | - | 1.46e-04 | 32 | 60 | 3 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.92e-04 | 35 | 60 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 2.09e-04 | 36 | 60 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 2.09e-04 | 36 | 60 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 2.09e-04 | 36 | 60 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.27e-04 | 37 | 60 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.27e-04 | 37 | 60 | 3 | PF00122 | |
| Domain | LH2 | 1.50e-03 | 18 | 60 | 2 | SM00308 | |
| Domain | PLAT | 2.05e-03 | 21 | 60 | 2 | PS50095 | |
| Domain | - | 2.05e-03 | 21 | 60 | 2 | 2.60.60.20 | |
| Domain | PLAT | 2.05e-03 | 21 | 60 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 2.05e-03 | 21 | 60 | 2 | IPR001024 | |
| Domain | HAD-like_dom | 2.10e-03 | 79 | 60 | 3 | IPR023214 | |
| Domain | ABC_transporter_CS | 8.05e-03 | 42 | 60 | 2 | IPR017871 | |
| Domain | WD40 | 9.60e-03 | 259 | 60 | 4 | PF00400 | |
| Domain | - | 1.00e-02 | 47 | 60 | 2 | 3.30.420.10 | |
| Domain | ABC_tran | 1.04e-02 | 48 | 60 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.04e-02 | 48 | 60 | 2 | PS50893 | |
| Domain | WD40 | 1.08e-02 | 268 | 60 | 4 | SM00320 | |
| Domain | ABC_TRANSPORTER_1 | 1.08e-02 | 49 | 60 | 2 | PS00211 | |
| Domain | AAA+_ATPase | 1.11e-02 | 144 | 60 | 3 | IPR003593 | |
| Domain | AAA | 1.11e-02 | 144 | 60 | 3 | SM00382 | |
| Domain | ABC_transporter-like | 1.13e-02 | 50 | 60 | 2 | IPR003439 | |
| Domain | WD40_repeat | 1.13e-02 | 272 | 60 | 4 | IPR001680 | |
| Domain | WD_REPEATS_1 | 1.22e-02 | 278 | 60 | 4 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.23e-02 | 279 | 60 | 4 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.23e-02 | 279 | 60 | 4 | PS50294 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 4.93e-06 | 11 | 45 | 3 | M27195 | |
| Pathway | KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION | 9.28e-06 | 42 | 45 | 4 | M16473 | |
| Pathway | KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION | 5.15e-05 | 23 | 45 | 3 | M4361 | |
| Pathway | WP_IL5_SIGNALING_PATHWAY | 6.36e-05 | 68 | 45 | 4 | MM15930 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 6.73e-05 | 69 | 45 | 4 | M48052 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.14e-04 | 79 | 45 | 4 | M17673 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.34e-04 | 176 | 45 | 5 | MM15718 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A1 ABCA1 TRPM5 ATP6V0A4 ATP1A1 MAGT1 ATP1A2 ATP1A3 ABCB1 | 2.52e-04 | 681 | 45 | 9 | MM14985 |
| Pathway | REACTOME_MAPK1_ERK2_ACTIVATION | 2.76e-04 | 8 | 45 | 2 | MM14507 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.80e-04 | 183 | 45 | 5 | M997 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.18e-04 | 103 | 45 | 4 | MM15196 | |
| Pathway | REACTOME_MAPK3_ERK1_ACTIVATION | 3.54e-04 | 9 | 45 | 2 | MM14474 | |
| Pathway | REACTOME_INTERLEUKIN_6_SIGNALING | 3.54e-04 | 9 | 45 | 2 | MM14470 | |
| Pathway | REACTOME_MAPK1_ERK2_ACTIVATION | 3.54e-04 | 9 | 45 | 2 | M26918 | |
| Pathway | REACTOME_MAPK3_ERK1_ACTIVATION | 4.41e-04 | 10 | 45 | 2 | M26896 | |
| Pathway | WP_EICOSANOID_LIPID_SYNTHESIS_MAP | 4.41e-04 | 10 | 45 | 2 | MM15916 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A1 ABCA1 TRPM5 ATP6V0A4 ATP1A1 MAGT1 ATP1A2 ATP1A3 ABCB1 | 4.47e-04 | 736 | 45 | 9 | M27287 |
| Pathway | REACTOME_INTERLEUKIN_6_SIGNALING | 5.38e-04 | 11 | 45 | 2 | M1014 | |
| Pathway | WP_IL4_SIGNALING | 6.73e-04 | 54 | 45 | 3 | M39720 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 6.73e-04 | 54 | 45 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 6.73e-04 | 54 | 45 | 3 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 7.10e-04 | 55 | 45 | 3 | M971 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 7.68e-04 | 130 | 45 | 4 | M27454 | |
| Pathway | PID_SHP2_PATHWAY | 7.88e-04 | 57 | 45 | 3 | M100 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 7.88e-04 | 57 | 45 | 3 | M39812 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 7.88e-04 | 57 | 45 | 3 | MM15643 | |
| Pathway | PID_IL5_PATHWAY | 8.85e-04 | 14 | 45 | 2 | M135 | |
| Pathway | REACTOME_REGULATION_OF_IFNG_SIGNALING | 8.85e-04 | 14 | 45 | 2 | M942 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.02e-03 | 15 | 45 | 2 | M552 | |
| Pathway | WP_ONCOSTATIN_M_SIGNALING | 1.16e-03 | 65 | 45 | 3 | M39562 | |
| Pathway | WP_AGERAGE_PATHWAY | 1.21e-03 | 66 | 45 | 3 | M39420 | |
| Pathway | KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY | 1.26e-03 | 67 | 45 | 3 | M10462 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 1.31e-03 | 17 | 45 | 2 | MM15096 | |
| Pathway | WP_LEPTININSULIN_SIGNALING_OVERLAP | 1.31e-03 | 17 | 45 | 2 | M39517 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 1.31e-03 | 17 | 45 | 2 | M919 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 1.44e-03 | 154 | 45 | 4 | M39007 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.68e-03 | 74 | 45 | 3 | M160 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.82e-03 | 76 | 45 | 3 | MM15051 | |
| Pathway | WP_LEPTIN_SIGNALING | 1.82e-03 | 76 | 45 | 3 | M39491 | |
| Pathway | WP_PROLACTIN_SIGNALING | 1.82e-03 | 76 | 45 | 3 | M39601 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 1.83e-03 | 20 | 45 | 2 | MM1529 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 1.83e-03 | 20 | 45 | 2 | MM15496 | |
| Pathway | WP_LEPTININSULIN_SIGNALING_OVERLAP | 1.83e-03 | 20 | 45 | 2 | MM15867 | |
| Pathway | WP_LIPID_METABOLISM_IN_SENESCENT_CELLS | 1.83e-03 | 20 | 45 | 2 | M45542 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.86e-03 | 165 | 45 | 4 | MM15026 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 2.01e-03 | 21 | 45 | 2 | M2623 | |
| Pathway | BIOCARTA_IL6_PATHWAY | 2.01e-03 | 21 | 45 | 2 | M5489 | |
| Pathway | BIOCARTA_INSULIN_PATHWAY | 2.01e-03 | 21 | 45 | 2 | M765 | |
| Pathway | REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING | 2.21e-03 | 22 | 45 | 2 | MM15319 | |
| Pathway | BIOCARTA_IGF1_PATHWAY | 2.21e-03 | 22 | 45 | 2 | MM1409 | |
| Pathway | BIOCARTA_IL6_PATHWAY | 2.21e-03 | 22 | 45 | 2 | MM1415 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 2.21e-03 | 22 | 45 | 2 | MM15675 | |
| Pathway | REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION | 2.21e-03 | 22 | 45 | 2 | MM14506 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 2.21e-03 | 22 | 45 | 2 | M22003 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 2.26e-03 | 82 | 45 | 3 | M1021 | |
| Pathway | REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION | 2.42e-03 | 23 | 45 | 2 | M26917 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 2.42e-03 | 23 | 45 | 2 | M39382 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 2.59e-03 | 86 | 45 | 3 | M916 | |
| Pathway | REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING | 2.63e-03 | 24 | 45 | 2 | M27604 | |
| Pathway | BIOCARTA_INSULIN_PATHWAY | 2.63e-03 | 24 | 45 | 2 | MM1425 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 2.63e-03 | 24 | 45 | 2 | M519 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 2.67e-03 | 87 | 45 | 3 | MM15915 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 3.08e-03 | 26 | 45 | 2 | M27750 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 3.08e-03 | 26 | 45 | 2 | M39687 | |
| Pathway | PID_IL3_PATHWAY | 3.08e-03 | 26 | 45 | 2 | M182 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 3.08e-03 | 26 | 45 | 2 | MM15896 | |
| Pathway | BIOCARTA_GH_PATHWAY | 3.32e-03 | 27 | 45 | 2 | M9043 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | 3.63e-03 | 471 | 45 | 6 | M39009 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 3.72e-03 | 327 | 45 | 5 | M27565 | |
| Pathway | PID_IGF1_PATHWAY | 3.83e-03 | 29 | 45 | 2 | M125 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.92e-03 | 203 | 45 | 4 | M5485 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 4.09e-03 | 30 | 45 | 2 | M41825 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 4.09e-03 | 30 | 45 | 2 | MM15866 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 2822726 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 17947306 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 28465228 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 18044013 | ||
| Pubmed | Na+/K+-ATPase α isoform deficiency results in distinct spreading depolarization phenotypes. | 5.13e-09 | 3 | 61 | 3 | 30819023 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 19058785 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 8203495 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 26911348 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 25994790 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 21731499 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 12458206 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 21849490 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 17446412 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 19751721 | ||
| Pubmed | Agrin regulation of alpha3 sodium-potassium ATPase activity modulates cardiac myocyte contraction. | 2.05e-08 | 4 | 61 | 3 | 19376779 | |
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 17234593 | ||
| Pubmed | Multiple genes encode the human Na+,K+-ATPase catalytic subunit. | 5.12e-08 | 5 | 61 | 3 | 3035563 | |
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 3036582 | ||
| Pubmed | Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. | 1.02e-07 | 6 | 61 | 3 | 10636900 | |
| Pubmed | Differential involvement of Na(+),K(+)-ATPase isozymes in preimplantation development of the mouse. | 1.79e-07 | 7 | 61 | 3 | 10837135 | |
| Pubmed | 1.79e-07 | 7 | 61 | 3 | 2158121 | ||
| Pubmed | Expression and distribution of Na, K-ATPase isoforms in the human uterus. | 1.79e-07 | 7 | 61 | 3 | 20065300 | |
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 19683723 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 2885848 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 23652595 | ||
| Pubmed | 4.28e-07 | 9 | 61 | 3 | 15253893 | ||
| Pubmed | Retinal pigment epithelial integrity is compromised in the developing albino mouse retina. | 1.12e-06 | 12 | 61 | 3 | 27097562 | |
| Pubmed | 1.84e-06 | 14 | 61 | 3 | 1572638 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15781423 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 7513703 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 9756938 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25955555 | ||
| Pubmed | Arachidonic acid metabolism regulates Escherichia coli penetration of the blood-brain barrier. | 3.03e-06 | 2 | 61 | 2 | 20696828 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 6324196 | ||
| Pubmed | Energy-sensitive regulation of Na+/K+-ATPase by Janus kinase 2. | 3.03e-06 | 2 | 61 | 2 | 24304834 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 32779889 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24860972 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 11507009 | ||
| Pubmed | The structure of the Na+,K+-ATPase and mapping of isoform differences and disease-related mutations. | 3.03e-06 | 2 | 61 | 2 | 18957371 | |
| Pubmed | All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides. | 3.03e-06 | 2 | 61 | 2 | 11546672 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24391932 | ||
| Pubmed | Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons. | 3.03e-06 | 2 | 61 | 2 | 23761886 | |
| Pubmed | Ion pumps in polarized cells: sorting and regulation of the Na+, K+- and H+, K+-ATPases. | 3.03e-06 | 2 | 61 | 2 | 11404365 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20952666 | ||
| Pubmed | The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit. | 3.03e-06 | 2 | 61 | 2 | 3030810 | |
| Pubmed | ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. | 3.03e-06 | 2 | 61 | 2 | 32155954 | |
| Pubmed | Expression of alpha isoforms of the Na,K-ATPase in human heart. | 3.03e-06 | 2 | 61 | 2 | 8391840 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 7559603 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21498719 | ||
| Pubmed | ABC proteins protect the human body and maintain optimal health. | 3.03e-06 | 2 | 61 | 2 | 21389634 | |
| Pubmed | Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive alpha1 Na+-K+-ATPase. | 3.03e-06 | 2 | 61 | 2 | 19376809 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 35446892 | ||
| Pubmed | The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. | 3.03e-06 | 2 | 61 | 2 | 8505282 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 14742675 | ||
| Pubmed | ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria. | 3.03e-06 | 2 | 61 | 2 | 33880529 | |
| Pubmed | DOCA-salt hypertension does not require the ouabain-sensitive binding site of the α2 Na,K-ATPase. | 3.03e-06 | 2 | 61 | 2 | 22258333 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22739122 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10360172 | ||
| Pubmed | ABCA1 Is Coordinated with ABCB1 in the Arsenic-Resistance of Human Cells. | 3.03e-06 | 2 | 61 | 2 | 29951962 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 7935386 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26154535 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 18003760 | ||
| Pubmed | Ouabain-Sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load. | 3.03e-06 | 2 | 61 | 2 | 18667729 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 21632957 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24356962 | ||
| Pubmed | 3.43e-06 | 17 | 61 | 3 | 36230906 | ||
| Pubmed | 4.88e-06 | 19 | 61 | 3 | 20861386 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 16055440 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 11557593 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 26158764 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 11208867 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 26050620 | ||
| Pubmed | In situ localization of sodium-potassium ATPase mRNA in developing mouse lung epithelium. | 9.07e-06 | 3 | 61 | 2 | 7573462 | |
| Pubmed | Identification of a VxP Targeting Signal in the Flagellar Na+ /K+ -ATPase. | 9.07e-06 | 3 | 61 | 2 | 26373354 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 18776170 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 7493946 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 9159180 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 15383549 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 16598312 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 9535915 | ||
| Pubmed | Association of common JAK2 variants with body fat, insulin sensitivity and lipid profile. | 9.07e-06 | 3 | 61 | 2 | 18239666 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 22565168 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 26988030 | ||
| Pubmed | Isoform specificity of the Na/K-ATPase association and regulation by phospholemman. | 9.07e-06 | 3 | 61 | 2 | 19638348 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21094218 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 8639815 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 14685860 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 27836549 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 12960006 | ||
| Pubmed | Relation between ABCB1 overexpression and COX2 and ALOX5 genes in human erythroleukemia cell lines. | 9.07e-06 | 3 | 61 | 2 | 33975019 | |
| Pubmed | Function of prokaryotic and eukaryotic ABC proteins in lipid transport. | 9.07e-06 | 3 | 61 | 2 | 15749056 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 18484747 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 33544780 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 18052210 | ||
| Pubmed | SHPTP2 serves adapter protein linking between Janus kinase 2 and insulin receptor substrates. | 9.07e-06 | 3 | 61 | 2 | 8912646 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 14627611 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 15485817 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 16243970 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 25194807 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 8995399 | ||
| Interaction | ATP1A2 interactions | 1.03e-05 | 45 | 61 | 4 | int:ATP1A2 | |
| Cytoband | 17q23.3 | 7.38e-04 | 30 | 61 | 2 | 17q23.3 | |
| Cytoband | 3p25.3 | 1.66e-03 | 45 | 61 | 2 | 3p25.3 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 5.72e-07 | 7 | 47 | 3 | 1208 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-09 | 175 | 61 | 7 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-07 | 173 | 61 | 6 | f0eb48c1283bdde313bb75f6ffc0d2626922d24b | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 170 | 61 | 5 | c638dfde9ce30190abbe0caea1c3eb874af09857 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 170 | 61 | 5 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 178 | 61 | 5 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.94e-06 | 181 | 61 | 5 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 4.94e-06 | 181 | 61 | 5 | 56fa77ae31f3b7de6e441a439c33a11353b6573a | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 7.10e-06 | 195 | 61 | 5 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-06 | 200 | 61 | 5 | ea039de8bd8b325845ce361f84e600c6dad922ed | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.56e-05 | 144 | 61 | 4 | 5e948d4cb913ccd8f82262a1b4d20967aadab3ab | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.73e-05 | 165 | 61 | 4 | 6799a6580c667738995cceb31cbf1c7fbdc4ff84 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.73e-05 | 165 | 61 | 4 | 8329d780f244bc31344443b29e5a00529a016662 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 167 | 61 | 4 | e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.29e-05 | 168 | 61 | 4 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.08e-05 | 172 | 61 | 4 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | 10x5'-GI_large-bowel-Mast|GI_large-bowel / Manually curated celltypes from each tissue | 1.04e-04 | 178 | 61 | 4 | d10ed2543c96e1a2373f847e0b82144771e26d07 | |
| ToppCell | 10x5'-GI_large-bowel-Mast-Mast_cells|GI_large-bowel / Manually curated celltypes from each tissue | 1.04e-04 | 178 | 61 | 4 | 8fc5f735afa25ae43c2acb1c710ade6e9e093e3c | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 180 | 61 | 4 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 180 | 61 | 4 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 181 | 61 | 4 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-04 | 184 | 61 | 4 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.18e-04 | 184 | 61 | 4 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 1.18e-04 | 184 | 61 | 4 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.18e-04 | 184 | 61 | 4 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.18e-04 | 184 | 61 | 4 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.18e-04 | 184 | 61 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 185 | 61 | 4 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.23e-04 | 186 | 61 | 4 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Tuft|World / Class top | 1.23e-04 | 186 | 61 | 4 | f4d83f15ab7b49c0920a322cd832413ece7c9948 | |
| ToppCell | Tuft-tuft-2|World / Class top | 1.25e-04 | 187 | 61 | 4 | 4ec6eee866619dfe13c84f5d2e812bb380d37139 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 61 | 4 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 61 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 61 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 1.33e-04 | 190 | 61 | 4 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 191 | 61 | 4 | 1f660ea2841324d13f63e01f1789e606c2843fc4 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 192 | 61 | 4 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 192 | 61 | 4 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-04 | 192 | 61 | 4 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 192 | 61 | 4 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 0ca0439dfdcb2361ca8d1015fb874a5b5c635d31 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | b397c14ac1e34c6be3f25d4417d200bc518d3048 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | d08919db9601941569b9a143dad4d8e6f56a4389 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 241a60d1f0d5832638fb3e1e4b7afa7387ea3c75 | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 1.41e-04 | 193 | 61 | 4 | 03a43b6d235fd47488a6a61efc311a34b232c0f4 | |
| ToppCell | (07)_Brush|World / shred by cell type and Timepoint | 1.41e-04 | 193 | 61 | 4 | 9af9d22a130ff97a9c37142a65e841b056d08640 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 194 | 61 | 4 | 48063c9fe3e12aeff0707acada1baa2f8621f093 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 194 | 61 | 4 | 4f31d2cf7eb37b45fefc4da5b41aac0bfdd847b3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 194 | 61 | 4 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 194 | 61 | 4 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 194 | 61 | 4 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.47e-04 | 195 | 61 | 4 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-04 | 195 | 61 | 4 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 1.47e-04 | 195 | 61 | 4 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-04 | 196 | 61 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 196 | 61 | 4 | 59b5b5a0c123d0423abd19c312514849004b903b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 197 | 61 | 4 | b16add329bb35a558287ede51353010dde5bc029 | |
| ToppCell | droplet-Heart-HEART|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 197 | 61 | 4 | 9654472f1d4c9a6caadf1ff61a84902d171e9eb4 | |
| ToppCell | droplet-Heart-HEART-1m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 197 | 61 | 4 | 1ec3c05a5d4163df2cf0d168e28a3f1d35364da2 | |
| ToppCell | distal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 198 | 61 | 4 | dc93886439a378a0c71e99acb8081bfb6b6d467b | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-04 | 198 | 61 | 4 | 0af55f2b859e4626e23e2733bf9ae2ace4547079 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 198 | 61 | 4 | 62059185afdf66126a6fbc899ce611c47e7a0feb | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell-Mast_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.56e-04 | 198 | 61 | 4 | f75800b4f3cf0d493226db8db7c949caade0ff90 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Mast_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.56e-04 | 198 | 61 | 4 | 45089e0adf2c00f4b0bccd701f4daebf25858006 | |
| ToppCell | distal-mesenchymal-Fibromyocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 198 | 61 | 4 | 9d1d95e7703cfc70a8ad427e400c340dbd205db8 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-Mast_cell-Mast_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-04 | 198 | 61 | 4 | 4163220f4ccb825a8399298cfac8411eb2acc9a2 | |
| ToppCell | distal-mesenchymal-Fibromyocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.56e-04 | 198 | 61 | 4 | fbfac1d10e4224990a094cc84b74bbc206881423 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 199 | 61 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.59e-04 | 199 | 61 | 4 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-04 | 199 | 61 | 4 | e1190b1c2d21fed313bb58e24d0e6365de6e6599 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.62e-04 | 200 | 61 | 4 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Macroglial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.62e-04 | 200 | 61 | 4 | 3a954d9d542e52c9b181f0850a09b1bff0a0c82d | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.62e-04 | 200 | 61 | 4 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.62e-04 | 200 | 61 | 4 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.62e-04 | 200 | 61 | 4 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.62e-04 | 200 | 61 | 4 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.62e-04 | 200 | 61 | 4 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.62e-04 | 200 | 61 | 4 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-04 | 200 | 61 | 4 | 2d2835f97e0ff4f99d384f18e10876575f6bdefd | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 78 | 61 | 3 | 1ddbb2247450a8b1c159f524dee15bf688748955 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_1-Tnr-Polydendrocyte.Tnr.Ctps_(Ctps)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.68e-04 | 78 | 61 | 3 | 2b0973122052bb26153f066e7b87c26f8a319698 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.81e-04 | 80 | 61 | 3 | 0d02b242164d27f38f70ed77b106612fc7a3abca | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.81e-04 | 80 | 61 | 3 | 313344cf7309bc17ca131b92a91b24489df577e2 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocyte.Tnr.Tmem2_(Tmem2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.81e-04 | 80 | 61 | 3 | b95e4456adb7f7d42825351f010376c10bb35380 | |
| Drug | 22,23-dihydrobufalin | 1.82e-07 | 5 | 61 | 3 | CID000195392 | |
| Drug | thevetin A | 1.82e-07 | 5 | 61 | 3 | CID000441873 | |
| Drug | 3-acetylstrophanthin | 1.82e-07 | 5 | 61 | 3 | CID003082282 | |
| Drug | ETH157 | 3.64e-07 | 6 | 61 | 3 | CID000563154 | |
| Drug | dihydrodigitoxigenin | 6.36e-07 | 7 | 61 | 3 | CID000107549 | |
| Drug | Digocin | 1.24e-06 | 70 | 61 | 5 | CID000003062 | |
| Drug | ouabagenin | 2.97e-06 | 11 | 61 | 3 | CID000010497 | |
| Drug | A-32686 | 5.13e-06 | 13 | 61 | 3 | CID000004951 | |
| Drug | verapamil | 5.91e-06 | 490 | 61 | 9 | CID000002520 | |
| Drug | Digoxin | 6.99e-06 | 46 | 61 | 4 | ctd:D004077 | |
| Drug | NSC-84513 | 8.14e-06 | 15 | 61 | 3 | CID000256927 | |
| Drug | HDMA | 1.21e-05 | 17 | 61 | 3 | CID000131092 | |
| Drug | amyl nitrite | 1.24e-05 | 53 | 61 | 4 | CID000008053 | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.29e-05 | 193 | 61 | 6 | 3906_DN | |
| Drug | AC1L1F3Q | 1.45e-05 | 18 | 61 | 3 | CID000003068 | |
| Drug | acetylstrophanthidin | 1.45e-05 | 18 | 61 | 3 | CID000006062 | |
| Drug | NSC 234205 | 1.45e-05 | 18 | 61 | 3 | CID000010104 | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 1.54e-05 | 199 | 61 | 6 | 3202_UP | |
| Drug | Ouabain | 1.69e-05 | 119 | 61 | 5 | ctd:D010042 | |
| Drug | oxovanadium | 1.76e-05 | 120 | 61 | 5 | CID000024411 | |
| Drug | Cymarigenen | 2.02e-05 | 20 | 61 | 3 | CID000005303 | |
| Drug | efonidipine | 2.11e-05 | 3 | 61 | 2 | ctd:C066425 | |
| Drug | AC1NST54 | 2.35e-05 | 21 | 61 | 3 | CID005315525 | |
| Drug | cardenolide | 3.12e-05 | 23 | 61 | 3 | CID000016142 | |
| Drug | AS701 | 4.22e-05 | 4 | 61 | 2 | CID000133528 | |
| Drug | Aldosterone | 6.03e-05 | 79 | 61 | 4 | ctd:D000450 | |
| Drug | AC1L9LNU | 6.33e-05 | 80 | 61 | 4 | CID000448157 | |
| Drug | trimethaphan | 6.65e-05 | 81 | 61 | 4 | CID000023576 | |
| Drug | cholesterol phosphate | 7.02e-05 | 5 | 61 | 2 | CID000134573 | |
| Drug | ETH615 | 7.02e-05 | 5 | 61 | 2 | CID000131627 | |
| Drug | Losartan | 8.06e-05 | 165 | 61 | 5 | ctd:D019808 | |
| Drug | poly(vinylidene fluoride | 9.60e-05 | 89 | 61 | 4 | CID000006369 | |
| Drug | 2,4-dinitrophenol | 1.00e-04 | 90 | 61 | 4 | CID000001493 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.04e-04 | 174 | 61 | 5 | 7530_DN | |
| Drug | pyrazoline | 1.05e-04 | 6 | 61 | 2 | CID000066962 | |
| Drug | sodium; lithium | 1.23e-04 | 36 | 61 | 3 | CID012725854 | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 1.31e-04 | 183 | 61 | 5 | 7062_DN | |
| Drug | isethionate | 1.44e-04 | 38 | 61 | 3 | CID000007866 | |
| Drug | AC1Q6A8A | 1.47e-04 | 7 | 61 | 2 | CID000160255 | |
| Drug | rishitin | 1.47e-04 | 7 | 61 | 2 | CID000108064 | |
| Drug | dihydropyrone | 1.47e-04 | 7 | 61 | 2 | CID000010760 | |
| Drug | N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine | 1.47e-04 | 7 | 61 | 2 | ctd:C481648 | |
| Drug | valinomycin | 1.56e-04 | 39 | 61 | 3 | CID000005649 | |
| Drug | orthovanadate | 1.59e-04 | 435 | 61 | 7 | CID000061672 | |
| Drug | aluminum chloride | 1.63e-04 | 102 | 61 | 4 | ctd:C010845 | |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; HL60; HT_HG-U133A | 1.64e-04 | 192 | 61 | 5 | 2580_UP | |
| Drug | tridigitoxoside | 1.68e-04 | 40 | 61 | 3 | CID000003061 | |
| Drug | tetrabenazine | 1.68e-04 | 40 | 61 | 3 | CID000006018 | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 1.72e-04 | 194 | 61 | 5 | 2504_UP | |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; PC3; HT_HG-U133A | 1.81e-04 | 196 | 61 | 5 | 4473_UP | |
| Drug | CID6432277 | 1.81e-04 | 41 | 61 | 3 | CID006432277 | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; HL60; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 3043_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.85e-04 | 197 | 61 | 5 | 7185_DN | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 5446_UP | |
| Drug | Oxybutynin chloride [1508-65-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 7126_UP | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.90e-04 | 198 | 61 | 5 | 4689_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; HL60; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 2563_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 2302_UP | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; HL60; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 1325_DN | |
| Drug | Orlistat; Down 200; 10uM; PC3; HT_HG-U133A | 1.94e-04 | 199 | 61 | 5 | 6420_DN | |
| Drug | 1,2,3,6-Tgg | 1.96e-04 | 8 | 61 | 2 | CID000073178 | |
| Drug | 11-keto-beta-boswellic acid | 1.96e-04 | 8 | 61 | 2 | CID006918114 | |
| Drug | thiopyrylium | 1.96e-04 | 8 | 61 | 2 | CID011344401 | |
| Drug | glutaconyl-CoA | 1.96e-04 | 8 | 61 | 2 | CID009543049 | |
| Drug | tiagabine | 1.96e-04 | 8 | 61 | 2 | ctd:C059205 | |
| Drug | Epiandrosterone [481-29-8]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.99e-04 | 200 | 61 | 5 | 4626_DN | |
| Drug | lithium aluminum hydride | 2.13e-04 | 320 | 61 | 6 | CID000028112 | |
| Drug | choline | 2.13e-04 | 320 | 61 | 6 | CID000000305 | |
| Drug | AC1MBZB6 | 2.51e-04 | 9 | 61 | 2 | CID002733620 | |
| Drug | AC1L1JI6 | 2.51e-04 | 9 | 61 | 2 | CID000005051 | |
| Drug | YM-26734 | 2.51e-04 | 9 | 61 | 2 | CID009853400 | |
| Drug | phenidone | 2.56e-04 | 46 | 61 | 3 | CID000007090 | |
| Drug | Sodium Chloride | 2.67e-04 | 116 | 61 | 4 | ctd:D012965 | |
| Drug | BMS-181162 | 3.13e-04 | 10 | 61 | 2 | CID006438744 | |
| Drug | gomisin A | 3.13e-04 | 10 | 61 | 2 | CID000068781 | |
| Drug | B669 | 3.13e-04 | 10 | 61 | 2 | CID000155807 | |
| Drug | AC1L5KHX | 3.13e-04 | 10 | 61 | 2 | CID000276752 | |
| Drug | zaprinast | 3.13e-04 | 10 | 61 | 2 | ctd:C011145 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 2.25e-07 | 7 | 56 | 3 | DOID:0060178 (implicated_via_orthology) | |
| Disease | nervous system disease (implicated_via_orthology) | 1.41e-06 | 12 | 56 | 3 | DOID:863 (implicated_via_orthology) | |
| Disease | ALTERNATING HEMIPLEGIA OF CHILDHOOD 1 | 3.54e-06 | 2 | 56 | 2 | C3549447 | |
| Disease | alternating hemiplegia of childhood (is_implicated_in) | 3.54e-06 | 2 | 56 | 2 | DOID:0050635 (is_implicated_in) | |
| Disease | end stage renal disease (implicated_via_orthology) | 7.21e-06 | 20 | 56 | 3 | DOID:783 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 1.09e-05 | 72 | 56 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 1.47e-05 | 163 | 56 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 2.03e-05 | 616 | 56 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.03e-05 | 616 | 56 | 8 | C0376358 | |
| Disease | Alternating hemiplegia of childhood | 2.12e-05 | 4 | 56 | 2 | C0338488 | |
| Disease | lung carcinoma (is_marker_for) | 3.52e-05 | 5 | 56 | 2 | DOID:3905 (is_marker_for) | |
| Disease | coronary artery disease (is_implicated_in) | 3.98e-05 | 100 | 56 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | Liver carcinoma | 4.75e-05 | 507 | 56 | 7 | C2239176 | |
| Disease | BMI-adjusted waist-hip ratio, forced expiratory volume | 5.28e-05 | 6 | 56 | 2 | EFO_0004314, EFO_0007788 | |
| Disease | response to vitamin | 9.83e-05 | 8 | 56 | 2 | GO_0033273 | |
| Disease | obstructive sleep apnea (biomarker_via_orthology) | 9.83e-05 | 8 | 56 | 2 | DOID:0050848 (biomarker_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 1.12e-04 | 49 | 56 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.12e-04 | 49 | 56 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | angiotensin-converting enzyme measurement | 1.26e-04 | 9 | 56 | 2 | EFO_0006515 | |
| Disease | familial Mediterranean fever (is_implicated_in) | 1.26e-04 | 9 | 56 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | epilepsy (is_implicated_in) | 1.26e-04 | 9 | 56 | 2 | DOID:1826 (is_implicated_in) | |
| Disease | Depressive disorder | 2.21e-04 | 289 | 56 | 5 | C0011581 | |
| Disease | hyperhomocysteinemia (biomarker_via_orthology) | 2.31e-04 | 12 | 56 | 2 | DOID:9279 (biomarker_via_orthology) | |
| Disease | Hematologic Neoplasms | 2.31e-04 | 12 | 56 | 2 | C0376545 | |
| Disease | leukemia (is_implicated_in) | 2.72e-04 | 13 | 56 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | Bipolar Disorder | 2.83e-04 | 477 | 56 | 6 | C0005586 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 3.16e-04 | 171 | 56 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | ulcerative colitis (is_implicated_in) | 4.72e-04 | 17 | 56 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | portal hypertension (implicated_via_orthology) | 5.93e-04 | 19 | 56 | 2 | DOID:10762 (implicated_via_orthology) | |
| Disease | ankylosing spondylitis (is_implicated_in) | 5.93e-04 | 19 | 56 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | epilepsy (biomarker_via_orthology) | 7.26e-04 | 21 | 56 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 7.44e-04 | 93 | 56 | 3 | C1535926 | |
| Disease | reticulocyte count | 7.57e-04 | 1045 | 56 | 8 | EFO_0007986 | |
| Disease | Myocardial Infarction | 7.92e-04 | 95 | 56 | 3 | C0027051 | |
| Disease | Coronary heart disease | 9.51e-04 | 24 | 56 | 2 | C0010068 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 9.51e-04 | 24 | 56 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 1.06e-03 | 105 | 56 | 3 | EFO_0007788, EFO_0008007, EFO_0008343 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.15e-03 | 108 | 56 | 3 | DOID:684 (biomarker_via_orthology) | |
| Disease | Major Depressive Disorder | 1.18e-03 | 243 | 56 | 4 | C1269683 | |
| Disease | Epilepsy | 1.18e-03 | 109 | 56 | 3 | C0014544 | |
| Disease | acute kidney failure (implicated_via_orthology) | 1.20e-03 | 27 | 56 | 2 | DOID:3021 (implicated_via_orthology) | |
| Disease | Schizophrenia | 1.36e-03 | 883 | 56 | 7 | C0036341 | |
| Disease | Mental Depression | 1.39e-03 | 254 | 56 | 4 | C0011570 | |
| Disease | Amyotrophic Lateral Sclerosis With Dementia | 1.39e-03 | 29 | 56 | 2 | C0393554 | |
| Disease | Myeloid Leukemia, Chronic | 1.39e-03 | 29 | 56 | 2 | C0023473 | |
| Disease | Carcinoma, Granular Cell | 1.41e-03 | 116 | 56 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.41e-03 | 116 | 56 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.41e-03 | 116 | 56 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.41e-03 | 116 | 56 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.41e-03 | 116 | 56 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.41e-03 | 116 | 56 | 3 | C0001418 | |
| Disease | Crohn's disease (is_implicated_in) | 1.49e-03 | 30 | 56 | 2 | DOID:8778 (is_implicated_in) | |
| Disease | Unipolar Depression | 1.49e-03 | 259 | 56 | 4 | C0041696 | |
| Disease | Autistic Disorder | 1.53e-03 | 261 | 56 | 4 | C0004352 | |
| Disease | Amyotrophic Lateral Sclerosis, Guam Form | 1.59e-03 | 31 | 56 | 2 | C0543859 | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 1.59e-03 | 31 | 56 | 2 | DOID:3328 (biomarker_via_orthology) | |
| Disease | fear of minor pain measurement | 1.59e-03 | 31 | 56 | 2 | EFO_0008340 | |
| Disease | Alcoholic Intoxication, Chronic | 1.69e-03 | 268 | 56 | 4 | C0001973 | |
| Disease | hypertension (implicated_via_orthology) | 1.87e-03 | 128 | 56 | 3 | DOID:10763 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SDNMQHAYWELKREM | 216 | Q9H6S1 | |
| AAMQSHMERAVWAAR | 171 | Q96EY9 | |
| IMHLWTMDSNFQRRY | 341 | Q76B58 | |
| TMLQQGWNATHMFRV | 311 | P12821 | |
| ELFSMRSWSDMRQEV | 271 | O95477 | |
| RSWSDMRQEVMFLTN | 276 | O95477 | |
| DMHSDMIYNVSWNRN | 171 | Q9ULV4 | |
| FQMDASCVNHWRAIM | 2121 | Q5JWR5 | |
| MTTFFSHNFNEDRWR | 1691 | Q8TDJ6 | |
| MMWSNFFLQEENRRR | 1 | Q9BXT2 | |
| YHNMFALMSETERIW | 81 | O60674 | |
| MVFRSMLRQDVSWFD | 791 | P08183 | |
| TYLDHNNFWRTMDDM | 111 | P27338 | |
| FMNQFLEHEWTNMQR | 576 | Q5VWQ8 | |
| FVLAMTSGQMWNHIR | 226 | Q9H0U3 | |
| NNSMWNEFYHRSTEM | 81 | Q8IWI9 | |
| FTVASLSYHRMWMVR | 106 | Q16538 | |
| QMESMKHNRTWDLEF | 551 | Q86W26 | |
| LTQNRMTVAHMWFDN | 381 | P05023 | |
| MQLESRWRQHFLDSM | 576 | Q9NVH0 | |
| WRHAFNVCQLMFAML | 666 | Q9HCR9 | |
| MEWRSSMEKNEHFLQ | 66 | Q6UY01 | |
| FWRMVFQENSRVIVM | 341 | Q06124 | |
| FWMQVDDSVVAQNMH | 236 | P35568 | |
| FYWILTMMQRTHSQE | 21 | O00222 | |
| SFMARFSELQWRMLA | 541 | Q9Y6A1 | |
| QNRMTVAHMWFDNQI | 381 | P50993 | |
| MSFADIMWRNHFAGR | 376 | Q8NE35 | |
| GEAAWFQVHRMLMFT | 406 | Q6ZNA5 | |
| MITVFSNRLGWHNME | 761 | O75417 | |
| LTQNRMTVAHMWFDN | 371 | P13637 | |
| LFMFRFGDHKARMNW | 231 | A6NKP2 | |
| VMTHRWNRFAMIVQG | 156 | P39059 | |
| RAFMDLTLMASWNQR | 2596 | Q8TDX9 | |
| QHMFRQAMRTPIIWF | 341 | Q8TEW0 | |
| YQSDNQASWIHRMIM | 456 | P47712 | |
| HWMFAMDNIIRRAVQ | 1111 | Q6ZN16 | |
| AMREWQHTSNFDRMI | 311 | Q5VT03 | |
| MREWQHTSNFDRMIF | 261 | A1L443 | |
| MREWQHTSNFDRMIF | 261 | Q5VZR2 | |
| MFRMLTNIWTVINHF | 81 | Q9NYV8 | |
| VFARVAQRWMEFMVQ | 2521 | Q5T011 | |
| TSAVVEFWERNMHQM | 186 | P30531 | |
| LLHRWFGTDMQMINF | 636 | A2VDJ0 | |
| INRFMHMFQSSWNDF | 191 | P09917 | |
| RDMTRMFVHPSFREW | 756 | Q9HCD6 | |
| YSVMGRSWEVQHMRQ | 331 | Q9NQW1 | |
| FEDNMETWMNNFHTL | 231 | P55060 | |
| TFHFLREEKFWMMDI | 56 | Q9UK11 | |
| VLQNRHEMATYFWAM | 526 | Q9NZQ8 | |
| YMTNRAEHDRMARQW | 181 | Q96LR5 | |
| QYRMHQAIMRWASDT | 441 | P38935 | |
| AFMVWSQHERRKIMD | 46 | O15370 | |
| HDRNPETWHMNFRMF | 36 | A6NJL1 | |
| ETWHMNFRMFSCPEE | 41 | A6NJL1 | |
| MSSSRAQQMHAFSWI | 1 | Q2KHR2 | |
| FRFFSMARDLLSWME | 1906 | P11277 | |
| MWSSQRFQAHLQEMG | 401 | Q9Y4R7 | |
| VHFMWEDVQQRGRVM | 176 | Q9NVA1 | |
| QFAFRWMNNLLMREV | 416 | Q8WUA7 | |
| MFRNGTWNTHVMEES | 486 | Q9HBG4 | |
| SMMVDHNIYVWDVRR | 271 | Q96S15 | |
| ALRFHMAAEEMEWFN | 101 | Q14691 |